BRIEF published on 09/03/2026 at 16:21, 13 days 8 hours ago Presentation of the Capital of Sartorius Stedim Biotech SA Share Capital Voting Rights Actions Regulation Sartorius Stedim
BRIEF published on 09/03/2026 at 16:21, 13 days 8 hours ago Sartorius Stedim Biotech Declares Share and Voting Rights Details Voting Rights Shares Regulatory Compliance Sartorius Stedim Biotech Issued Capital
PRESS RELEASE published on 09/03/2026 at 16:16, 13 days 8 hours ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights in the issued capital. Important regulatory announcement disclosed Voting Rights Capital Shares Sartorius Stedim Biotech Regulatory Announcement
BRIEF published on 08/04/2026 at 10:16, 1 month 12 days ago Sartorius Stedim Biotech Announces Share and Voting Rights Update Voting Rights Shares Regulatory Compliance Sartorius Stedim Biotech Issued Capital
BRIEF published on 08/04/2026 at 10:16, 1 month 12 days ago Sartorius Stedim Biotech: Declaration of Shares and Voting Rights Share Capital Voting Rights Actions Finance Sartorius Stedim
PRESS RELEASE published on 08/04/2026 at 10:12, 1 month 12 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA in France discloses total shares and voting rights as of July 31, 2026, in accordance with legal requirements Voting Rights Shares Disclosure Sartorius Stedim Biotech France
PRESS RELEASE published on 08/04/2026 at 10:11, 1 month 12 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares number of shares and voting rights in issued capital as of July 31, 2026. Regulatory announcement Voting Rights Shares Sartorius Stedim Biotech Regulatory Announcement Capital Declaration
PRESS RELEASE published on 07/23/2026 at 09:22, 1 month 24 days ago First-Half Financial Report January to June 2026
BRIEF published on 07/23/2026 at 07:05, 1 month 24 days ago Sartorius Stedim Biotech Shows Steady Growth Amid Tariff Adjustments EBITDA Margin Sales Revenue Product Launches Biotech Growth Tariff Impact
BRIEF published on 07/23/2026 at 07:05, 1 month 24 days ago Sartorius Stedim Biotech's half-year performance in 2026 EBITDA Revenue Sartorius Stedim Biotech Half-year Growth Customs Duties
Published on 09/16/2026 at 23:45, 1 hour 28 minutes ago Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 3 hours 43 minutes ago Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 8 hours 18 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 10 hours 13 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 11 hours 13 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/16/2026 at 23:45, 1 hour 27 minutes ago WESCAN GOLDFIELDS COMMENCES UAV MAGNETIC AND LIDAR SURVEYS AT MUNRO LAKE PROJECT
Published on 09/16/2026 at 22:33, 2 hours 39 minutes ago EQS-Adhoc: Bilfinger adjusts outlook for 2026 and resolves program “Agile”
Published on 09/16/2026 at 21:15, 3 hours 57 minutes ago Gastech 2026 in Bangkok Converts Global Energy Ambition into Billions of Dollars in Deals
Published on 09/16/2026 at 20:27, 4 hours 45 minutes ago EQS-Adhoc: REPLOID Group AG resolves to issue convertible notes in an aggregate principal amount of up to EUR 30 million
Published on 09/16/2026 at 19:05, 6 hours 7 minutes ago EcoFlow to showcase its open home energy ecosystem at Solar & Storage Live Zurich 2026
Published on 09/16/2026 at 17:45, 7 hours 28 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 18 hours 13 minutes ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 7 hours ago Report on the Combined General Meeting of the 10th of September 2026
